Related references
Note: Only part of the references are listed.Drug Uptake Systems in Liver and Kidney: A Historic Perspective
B. Hagenbuch
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Genetic variants of human organic anion transporter 4 demonstrate altered transport of endogenous substrates
James E. Shima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms
Henriette E. Meyer Zu Schwabedissen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Effects of Drug Transporters on Volume of Distribution
Anita Grover et al.
AAPS JOURNAL (2009)
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
Martee L. Hensley et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Impact of Genetic Polymorphisms of Transporters on the Pharmacokinetic, Pharmacodynamic and Toxicological Properties of Anionic Drugs
Kazuya Maeda et al.
DRUG METABOLISM AND PHARMACOKINETICS (2008)
Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
Mitsunori Okabe et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics
Volker Vallon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G
Adam L. VanWert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Mesna as a nonvitamin intervention to lower plasma total homocysteine concentration: Implications for assessment of the homocysteine theory of atherosclerosis
Bradley L. Urquhart et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values
Andrew S. Levey et al.
CLINICAL CHEMISTRY (2007)
Intestinal drug transporter expression and the impact of grapefruit juice in humans
H. Glaeser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex
S. Haenisch et al.
PHARMACOGENOMICS JOURNAL (2007)
Irinotecan-induced diarrhea: Functional significance of the polymorphic ABCC2 transporter protein
F. A. de Jong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
High-dose methotrexate in pediatric acute lymphoblastic leukemia:: Impact of ABCC2 polymorphisms on plasma concentrations
Thomas Rau et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Thiol exchange:: An in vitro assay that predicts the efficacy of novel homocysteine lowering therapies
Bradley L. Urquhart et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Drug-drug interactions involving membrane transporters in the human kidney
Meng Li et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins
Roger G. Deeley et al.
PHYSIOLOGICAL REVIEWS (2006)
The human organic anion transporter 3 (OAT3; SLC22A8):: genetic variation and functional genomics
AR Erdman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice
SA Eraly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A human transporter protein that mediates the final excretion step for toxic organic cations
M Otsuka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects
KA Kim et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule
E Boven et al.
BRITISH JOURNAL OF CANCER (2005)
Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics
N Yasui-Furukori et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Transporters and drug therapy: Implications for drug disposition and disease
RH Ho et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats
M Verschraagen et al.
BRITISH JOURNAL OF CANCER (2004)
Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules
S Ekaratanawong et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects
M Verschraagen et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Pharmacoldnetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites
M Verschraagen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Simultaneous determination of BNP7787 and its metabolite mesna in plasma and tissue by micro-HPLC with a dual electrochemical detector
M Verschraagen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation
RG Tirona et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Quantification of BNP7787 (dimesna) and its metabolite mesna in human plasma and urine by high-performance liquid chromatography with electrochemical detection
M Verschraagen et al.
JOURNAL OF CHROMATOGRAPHY B (2001)